MALIGNANT SOLID TUMORS
Clinical trials for MALIGNANT SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMORS trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets hard-to-treat solid tumors
Disease control Not yet recruitingThis study tests a new drug, JCXH-211, injected directly into tumors along with an anti-PD-1 antibody given through an IV. It is for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the combination is safe and tolerable …
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New cancer drug SHR-4298 enters early human testing
Disease control Not yet recruitingThis study is testing an experimental drug called SHR-4298 in 200 people with advanced solid tumors that cannot be removed by surgery or cured by standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors or slow cancer…
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New Dual-Target PET probe aims to sharpen cancer detection
Diagnosis Not yet recruitingThis study will test a new imaging agent called 68Ga-B6FA-01, which targets two different markers on cancer cells and their surroundings. The goal is to see if this probe can improve PET/CT scans for diagnosing and staging solid tumors. About 100 adults with newly diagnosed or re…
Matched conditions: MALIGNANT SOLID TUMORS
Sponsor: Zhongnan Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC